홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

시트르산칼륨(구연산칼륨)

Potassium Citrate

HCID 2735208
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
6100-05-6
표준 SMILES
O.O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[K+].[K+].[K+]
InChIKey
PJAHUDTUZRZBKM-UHFFFAOYSA-K
분자식
C6.H7.K3.O8
평균 분자량
324.41 g/mol
단동위원소 질량
323.9052116

개요

Potassium citrate monohydrate is a hydrate that is the monohydrate form of potassium citrate. It has a role as a diuretic. It contains a potassium citrate (anhydrous).

이름 및 식별자

우선 이름
Potassium Citrate
IUPAC
tripotassium;2-hydroxypropane-1,2,3-tricarboxylate;hydrate
현지명
시트르산칼륨(구연산칼륨)
영어명
Potassium citrate monohydrate
분자식
C6H11KO8
분자량
250.24

이름 및 동의어

Potassium citrate monohydrateKalii citrasUROCIT-KK-cit-vEffercitrateCymaclearINS NO.332(II)Potassium-citKali CitricumEE90ONI6FFPot citINS-332(II)
이름 더 보기
시트르산칼륨시트르산칼륨(구연산칼륨)칼륨시트레이트모노하이드레이트트리베이직칼륨시트르산,모노수화물칼륨시트르산,모노수화물(POTASSIUMCITRATE,MONOHYDRATE)구연산칼륨1수화물TRIPOTASSIUM CITRATE MONOHYDRATEHydroxycitric acid (tripotassium hydrate)Potassium citrate hydrateCITRIC ACID TRIPOTASSIUM SALT MONOHYDRATEKH2PO49tri-Potassium citrateTrikaliumcitratH2O,BPPotassium Citrate FCC
E-332(II)NSC-760107CHEBI:64746Pot cit effUrocit-k 5meqCitrate, PotassiumRefChem:6154DTXSID0041222

데이터베이스 식별자

CAS
6100-05-6、866-84-2

물성

구조 계산 물성

극성 표면적
142 Ų
수소 결합 공여자 수
2
수소 결합 수용자 수
8
회전 가능 결합 수
2
무거운 원자 수
17
형식 전하
0
복잡도
211

실험 및 물리화학적 성질

Chemical ClassesMetals -> Organic Acids, Metal Salts
CosmeticsCosmetic ingredients (Potassium Citrate) -> CIR (Cosmetic Ingredient Review)
Food AdditivesEMULSIFIER OR EMULSIFIER SALT, FLAVOR ENHANCER, FLAVORING AGENT OR ADJUVANT, NUTRIENT SUPPLEMENT, PH CONTROL AGENT, SEQUESTRANT -> FDA Substance added to food
Density1.98 @25 °C
Human Drugs · 2건

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Animal DrugsFDA approved animal drugs -> Active ingredient
Food Contact SubstancesFCS -> FDA Inventory of Food Contact Substances Listed in 21 CFR
Physical DescriptionWhite odorless solid; [Merck Index] White powder or granules; [Alfa Aesar MSDS]

물리화학적 성질

녹는점
275 °C · 275 °C (dec.)(lit.)
밀도
1.98 · 1.98

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 4건

This chemical does not meet GHS hazard criteria for 100% (181 of 181) of all reports.

Not Classified

Aggregated GHS information provided per 181 reports by companies from 2 notifications to the ECHA C&L Inventory.

Not Classified

유해성 정보

Regulatory Information · 2건

Chemical: 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, tripotassium salt, monohydrate

Tripotassium citrate monohydrate: Does not have an individual approval but may be used under an appropriate group standard

Other Safety InformationIMAP assessments - 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, tripotassium salt, monohydrate: Human health tier I assessment
Hazards SummaryMay cause irritation; [Alfa Aesar MSDS] See Tripotassium citrate.
EPA Safer ChemicalChemical: Potassium citrate, monohydrate
Hazard Classes and Categories · 2건

Not Classified

Not Classified

안전 및 보호

Protective Action Criteria (PAC) · 6건

2.1 [mg/m3]

23 [mg/m3]

140 [mg/m3]

2.2 [mg/m3]

24 [mg/m3]

150 [mg/m3]

독성 정보

Toxicity Summary

화학 및 산업

약리 정보

ATC Code · 2건

A - Alimentary tract and metabolism

QA - Alimentary tract and metabolism

Pharmacodynamics · 1건

Potassium citrate induces changes in the urine which renders urine less susceptible to the formation of crystals and stones from salts e.g. calcium oxalate, calcium phosphate and uric acid. Increased citrate levels in the urine will make complexation with calcium which decrease the calcium ion activity and decrease the chance for the formation of calcium phosphate crystals. Citrate also inhibits the spontaneous nucleation of calcium oxalate and calcium phosphate.

Mechanism of Action · 1건

After oral administration of potassium citrate, its metabolism yields alkaline load. Potassium Citrate therapy appears to increase urinary citrate mainly by modifying the renal handling of citrate, rather than by increasing the filtered load of citrate. In addition to raising urinary pH and citrate, Potassium Citrate increases urinary potassium by approximately the amount contained in the medication. In some patients, Potassium Citrate causes a transient reduction in urinary calcium.

Metabolism/MetabolitesPotassium Citrate is absorbed and the citrate is metabolised to bicarbonate.
FDA Pharmacological Classification · 4건

KALI CITRICUM

Acidifying Activity [MoA]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]; Calculi Dissolution Agent [EPC]; Decreased Coagulation Factor Activity [PE]

POTASSIUM CITRATE

Calcium Chelating Activity [MoA]; Calculi Dissolution Agent [EPC]; Decreased Coagulation Factor Activity [PE]; Acidifying Activity [MoA]; Anti-coagulant [EPC]

MeSH Pharmacological Classification · 2건

Agents that promote the excretion of urine through their effects on kidney function.

Agents that increase mucous excretion. Mucolytic agents, that is drugs that liquefy mucous secretions, are also included here.

관련 반응

3건
반응 기록 만들기
HRID 991370 반응식
HRID 991370반응물로
HRID 1278511 반응식
HRID 1278511반응물로
HRID 2084984 반응식
HRID 2084984반응물로

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
PubChem CID
2735208
DTXSID
DTXSID8042501
ChEMBL
CHEMBL3989822
ChEBI
CHEBI:64746
UNII
EE90ONI6FF
EC Number
612-062-1、934-739-3
저장 조건
Inert atmosphere,Room Temperature
용해도
2 O: · H2O: 1 M at 20 °C, 투명, 무색
물리적 상태
세분화된
Specific Gravity
1.98 · 1.98
색상
백색 결정체
냄새
냄새 없는
수소이온지수(pH)
7.5 · 7.5-9.0 (25℃, 50mg/mL in H2O)
수용성
물과 글리세롤에 용해됩니다. 알코올에는 거의 녹지 않으며 물과 글리세롤에는 용해됩니다. 알코올에 불용성
Merck
14 · 14,7623
BRN
3924344 · 3924344
안정성
안정적인. 강한 산화제와 호환되지 않습니다.
InChI
1S/C6H8O7.3K.H2O/c7-3(8)1-6(13,5(11)12)2-4(9)10;;;;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;;1H2/q;3*+1;/p-3
InChIKey
PJAHUDTUZRZBKM-UHFFFAOYSA-K
SMILES
O.[K+].[K+].[K+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
EPA
Tripotassium citrate monohydrate (6100-05-6)

화학적 성질

White/clear crystalline powder

Safe in the present practices of use and concentration. Ingredient, concentration, and use information are available in documents discoverable at https://cir-reports.cir-safety.org

안전 데이터

wgk
1
tsca
Yes
HS 번호
29181500
risk_code
22-35
hazard_code
F,T,C,Xi
safety_code
26-36/37/39-45-24/25
F 고인화성물질
3
스토리지 클래스
11 - Combustible Solids
Absorption, Distribution and Excretion
Urinary; less than 5% unchanged.

용도 및 제조

Uses · 2건

CIR ingredient: Potassium Citrate

Used in food (sequestrant, emulsifier, and stabilizer) and in medicine as an alkalinizing agent and antiurolithic; [Merck Index] Used as a flavoring agent, nutritional supplement, pH control agent, and sequestrant for foods; [FDA]

Household Products · 2건

Information on 2 consumer products that contain Potassium Citrate in the following categories is provided:

Information on 29 consumer products that contain Potassium Citrate in the following categories is provided:

Use Classification · 3건

EPA Safer Chemical Functional Use Classes -> Chelating Agents;Processing Aids and Additives

Safer Chemical Classes -> Green circle - The chemical has been verified to be of low concern

Food Additives -> ACIDITY_REGULATOR; SEQUESTRANT; STABILIZER -> JECFA Functional Classes

응용 분야 · 2건

용도Tripotassium Citrate Monohydrate is used in manufacturing method of printed circuit board for autonomous vehicle to perform recognition, judgment, determination and execution.Citric acid is a weak organic acid that is known as a commodity chemical, as more than a million tonnes are produced every year by mycological fermentation on an industrial scale using crude sugar solutions, such as molasses and strains of Aspergillus niger. Citric acid is widely distributed in plants and in animal tissues and fluids and exist in greater than grace amounts in variety of fruits and vegetables, most notably in citrus fruits such as lemon and limes. Citric acid is mainly used as an acidifier, flavoring agent and chelating agent. Citric acid is also a metabolite of Dimethyl Fumarate (D464965), a compound

일반 설명Potassium citrate tribasic monohydrate (KCTM) is a potassium salt that has been reported to be efficient in forming aqueous two-phase system (ATPS) with UCON 50-HB-5100, a random copolymer. This product is a high quality pharmacopoeia product that meets the testing specifications of USP (United States Pharmacopoeia). It can be employed in research and pilot studies.

제조 방법 · 1건

생산 방법Potassium citrate is prepared by adding either potassium bicarbonate or potassium carbonate to a solution of citric acid until effervescence ceases. The resulting solution is then filtered and evaporated to dryness to obtain potassium citrate.

상·하류 제품 정보

상류 원료

이탄산 칼륨탄산 칼륨시트르산
추가 설명 · 3건

순도시험(1) 비소 : 이 품목을 비소시험법에 따라 시험할 때, 그 양은 1.3ppm 이하이어야 한다. (2) 납 : 이 품목 5.0g을 취하여 원자흡광광도법 또는 유도결합플라즈마발광광도법에 따라 시험할 때, 그 양은 1.0ppm 이하이어야 한다. (3) 수은 : 이 품목을 수은시험법에 따라 시험할 때, 그 양은 1.0ppm 이하이어야 한다. (4) 알칼리도 : 이 품목의 수용액(1→20)은 리트머스시험지에 반응시킬 때, 알칼리성을 나타낸다.

정량법이 품목을 건조한 다음 250mg을 정밀히 달아 빙초산 40mL를 넣어 약간 가열하여 용해시킨 후 실온으로 냉각하여 0.1N 과염소산용액으로 적정한다(지시약 : 크리스탈바이올렛․빙초산시액 2방울). 따로 같은 방법으로 공시험을 한다.0.1N 과염소산용액 1mL = 10.213mg C6H5K3O7

정의ChEBI: A hydrate that is the monohydrate form of potassium citrate.